Drugs / Hylorunic acid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06901895 | Mar → Jul 2025 overdue | dry eye syndrome | Superior University | Active not recruiting | No outcome recorded |
| — | NCT06913556 | Mar → Jun 2025 overdue | dry eye syndrome | Superior University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hylorunic acid | “In group 1 we access preoperative dry eyes condition and postoperatively we access the condition in 2nd and 4th week with the use of Hylorunic acid lubricant.” NCT06913556 ↗ |
| Known as | hylo | “Hylorunic acid (hylo) eye drop is prescribed and check the curative effect after phacoemulsification after 2nd and 4th week.” NCT06901895 ↗ |